Pik3ip1 Modulates Cardiac Hypertrophy by Inhibiting PI3K Pathway

Cardiac hypertrophy is an adaptive response to various physiological and pathological stimuli. Phosphoinositide-3 kinase (PI3K) is a highly conserved lipid kinase involved in physiological cardiac hypertrophy (PHH). PI3K interacting protein1 (Pik3ip1) shares homology with the p85 regulatory subunit of PI3K and is known to interact with the p110 catalytic subunit of PI3K, leading to attenuation of PI3K activity in liver and immune cells. However, the role of Pik3ip1 in the heart remains unknown. In the present study, the effects of Pik3ip1 on cardiac hypertrophy were examined. We found that the expression level of Pik3ip1 was markedly higher in cardiomyocytes than in fibroblasts. The interaction of Pik3ip1 with the p110a subunit of PI3K in the heart was identified by immunoprecipitation using neonatal rat cardiomyocytes (NRCM). Approximately 35% knockdown of Pik3ip1 was sufficient to induce myocardial hypertrophy. Pik3ip1 deficiency was shown to lead to activation of PI3K/protein kinase B (AKT)/ mammalian target of rapamycin (mTOR) signaling pathway, increasing protein synthesis and cell size. However, adenovirus-mediated overexpression of Pik3ip1 attenuated PI3K-mediated cardiac hypertrophy. Pik3ip1 was upregulated by PHH due to swimming training, but not by pathological cardiac hypertrophy (PAH) due to pressure-overload, suggesting that Pik3ip1 plays a compensatory negative role for PHH. Collectively, our results elucidate the mechanisms for the roles of Pik3ip1 in PI3K/AKT signaling pathway.     

Nanopore sequencing reveals full-length Tropomyosin 1 isoforms and their regulation by RNA-binding proteins during rat heart development

Alternative splicing (AS) contributes to the diversity of the proteome by producing multiple isoforms from a single gene. Although short-read RNA-sequencing methods have been the gold standard for determining AS patterns of genes, they have a difficulty in defining full-length mRNA isoforms assembled using different exon combinations. Tropomyosin 1 (TPM1) is an actin-binding protein required for cytoskeletal functions in non-muscle cells and for contraction in muscle cells. Tpm1 undergoes AS regulation to generate muscle versus non-muscle TPM1 protein isoforms with distinct physiological functions. It is unclear which full-length Tpm1 isoforms are produced via AS and how they are regulated during heart development. To address these, we utilized nanopore long-read cDNA sequencing without gene-specific PCR amplification. In rat hearts, we identified full-length Tpm1 isoforms composed of distinct exons with specific exon linkages. We showed that Tpm1 undergoes AS transitions during embryonic heart development such that muscle-specific exons are connected generating predominantly muscle-specific Tpm1 isoforms in adult hearts. We found that the RNA-binding protein RBFOX2 controls AS of rat Tpm1 exon 6a, which is important for cooperative actin binding. Furthermore, RBFOX2 regulates Tpm1 AS of exon 6a antagonistically to the RNA-binding protein PTBP1. In sum, we defined full-length Tpm1 isoforms with different exon combinations that are tightly regulated during cardiac development and provided insights into the regulation of Tpm1 AS by RNA-binding proteins. Our results demonstrate that nanopore sequencing is an excellent tool to determine full-length AS variants of muscle-enriched genes.     

The Role of Guanine Nucleotide Binding Proteins in Hamsters with Myocardial Hypertrophy

Abstract

To clarify the role of the guanine nucleotide binding proteins (G-proteins) in the pathogenesis of myocardial hypertrophy, we investigated the alterations in myocardial G proteins in 20-week-old F1b hamsters with pressure overload induced for 3 days (3-day AS), 7 days (7-day AS) and 14 days (14-day AS) by the stenosis of the abdominal aorta, and in 4- and 20 week-old BIO 14.6 Syrian hamsters (4-wk and 20-wk BIO) with genetic myocardial hypertrophy. The hearts of 7-day AS, 14-day AS and 20-wk BIO with left ventricular hypertrophy exhibited a decrease in the mRNA levels detected by Northem blot analysis and protein levels of G protein detected by Western blot analysis as compared with sham-operated and age-matched F1b hearts. The function of Gs or Gi showed a concomitant reduction in both models of myocardial hypertrophy. The hearts of 3-day AS and 4-wk BIO without myocardial hypertrophy showed no changes in G proteins as compared with sham-operated and age-matched F1b hearts. These results suggest that a decrease in G proteins is not involved in the pathogenesis of myocardial hypertrophy, but that myocardial hypertrophy reduced the G proteins.     

沙葱萤叶甲卵滞育的转录组学分析

【目的】建立沙葱萤叶甲Galeruca daurica滞育卵转录组数据库,挖掘卵滞育相关的基因以及代谢和信号通路,在转录组水平探讨卵滞育的分子机制。【方法】采用Illumina NovaSeq6000高通量测序平台对沙葱萤叶甲滞育卵与解除滞育卵进行转录组测序,并进行生物信息学分析;利用DESeq软件分析沙葱萤叶甲滞育卵与解除滞育卵中的差异表达基因,对差异表达基因进行KEGG通路富集分析;利用qRT PCR技术对10个差异表达基因的表达模式进行验证。【结果】基于沙葱萤叶甲滞育卵与解除滞育卵转录组测序结果,共获得53 389个unigene,其中差异表达基因2 145个,24个差异表达基因与保幼激素信号及脂肪酸生物合成和降解相关。与解除滞育卵相比,滞育卵转录组中1 297个基因上调表达,富集于124条KEGG通路,其中核糖体通路显著富集;848个基因下调表达,富集于73条KEGG通路,其中MAPK信号通路和糖胺聚糖生物合成通路显著富集。qRT-PCR结果表明,随机选取的10个差异表达基因的表达趋势与RNA-Seq转录组测序结果完全一致。【结论】保幼激素,脂肪酸生物合成和降解,核糖体,MAPK信号及糖胺聚糖生物合成等通路可能在沙葱萤叶甲卵滞育调控中起着重要的作用。     

沙葱萤叶甲成虫不同夏滞育阶段的转录组分析(英文)

【目的】本研究旨在揭示内蒙古草原新害虫沙葱萤叶甲Galeruca daurica专性夏滞育相关的重要基因以及代谢通路。【方法】应用RNA-Seq技术,对沙葱萤叶甲成虫不同夏滞育阶段［滞育前期(PD)、滞育期(D)及滞育后期(TD)］进行转录组测序、分析及基因功能预测,基于RNA-Seq数据筛选夏滞育不同阶段差异表达基因;利用qPCR对基于RNA-Seq数据筛选的10个差异表达基因的表达水平进行验证。【结果】从9个文库中获得202 770 198 clean reads,将12 078 060条转录本组装获得82 292 条unigene,平均长度为783.59 bp,N50为1 545 bp。沙葱萤叶甲D vs PD和TD vs D 比较组分别有2 395(2 119上调和277下调)和62(59上调和3下调)个差异基因。KEGG分析表明,D vs PD和TD vs D比较组差异表达基因分别显著富集于糖孝解/糖异生通路和脂肪酸生物合成通路;此外,许多与钙离子信号转导相关的基因在滞育期间差异表达。10个差异表达基因的qPCR分析表明,RNA-Seq与qPCR结果高度一致。【结论】糖孝解/糖异生、脂肪酸生物合成及钙离子信号通路可能在沙葱萤叶甲滞育调节中起着重要的作用。本研究为进一步研究沙葱萤叶甲成虫专性夏滞育的分子机理奠定了基础。